Die Oxford Business Group  hat einen Bericht zum Fortschritt auf dem nigerianischen Gesundheitsmarkt veröffentlicht und schreibt dazu:

“Nigeria has made tangible progress on health indicators in recent years, although structural challenges remain. While the government will continue to play a central role in the pursuit of universal health care, there are opportunities for private sector participation to help achieve its ambitious goals. The Nigeria Health Focus Report analyses how the country has strengthened its capacity to circumvent domestic and imported counterfeit drugs, and explores opportunities for investment as the government promotes local production, particularly of essential medicines.

This Focus Report includes an interview with Mojisola Adeyeye, director-general of the National Agency for Food and Drug Administration and Control, and contains in-depth case studies and viewpoints from key industry players.”